Our Clients

Contact Us

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

How long does it takes to we get back to you

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

(insert contact form here)

LAtest NEws

Liposomes Improve Delivery and Efficacy of Skin Care Products

“This study shows that Liposomal Blend is a vehicle with the ability to enhance the [...]

04
Dec
Novel Preparation and Analysis of Liposomal NMN

The study developed a novel microfluidic approach to co-encapsulate NMN and an anticancer drug, honokiol [...]

30
Nov
High-Dose NR is Safe & Does Not Deplete Methyl Pools in PD Trial

This study evaluated the safety and effects of high-dose (3,000 mg) Nicotinamide Riboside (NR) supplementation [...]

29
Nov
Clinical Trial Fails to Find Significant Benefit of NR in Adults with MCI

This study showed that NR (1 g/day) for 10 weeks is safe in adults with [...]

28
Nov
Advancements in NAD+ Research

New research on NAD+ metabolism, NMN supplementation, and mitochondrial NAD+ levels was presented at the [...]

27
Nov
Efficacy and Safety of NAD+ Precursors in Clinical Trials

A recent systematic review evaluated ten studies with NAD+ precursors for efficacy and safety.

[...]
23
Nov
NMN Enhanced HIV-1 Therapy in Mice

“Results from the humanized mouse study demonstrated that NMN treatment could improve the therapeutic effect [...]

22
Nov
Health Conditions Linked to NAD+ Decline

Many diseases and biological stressors disrupt NAD+ metabolism and are associated with low levels of [...]

17
Nov